Engelhart James

Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd.

Sold, on record
$9.9M
Dollars the filings state
Form 4 sales
7
Latest Dec 10, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Nov 10, 2017 2017

    Sold 30,538 shares at $26.58 ($812k)

    Engelhart James, Chief Financial Officer

    Sold 89.5% of holdings ($907k position)3,576 shares leftFirst sale on recordFiling

  2. Jan 22, 2018 +73 days

    Sold 10,000 shares at $32.50 ($325k)

    Engelhart James, Chief Financial Officer

    Sold 73.7% of holdings ($441k position)3,576 shares leftFiling

  3. 3 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not stated
    Feb 21, 2018 +30 days

    Sold 538 shares at $29.60 ($16k)

    Engelhart James, Chief Financial Officer

    Sold 15% of holdings ($106k position)3,038 shares leftFiling

  4. May 7, 2018 +75 days

    Sold 2,500 shares at $27.67 ($69k)

    Engelhart James, Chief Financial Officer

    Sold 100% of holdings ($69k position)0 shares left0.3x usual sizeFiling

  5. May 30, 2018 +23 days

    Sold 5,000 shares at $35.00 ($175k)

    Engelhart James, Chief Financial Officer

    Sold 100% of holdings ($175k position)0 shares left0.8x usual sizeFiling

  6. Jun 11, 2020 +743 days

    Sold 73,725 shares at $66.09 ($4.9M)

    Engelhart James, Chief Financial Officer

    Sold 94.2% of holdings ($5.2M position)4,522 shares leftFirst sale on recordFiling

  7. Dec 10, 2021 +547 days

    Sold 35,000 shares at $102.55 ($3.6M)

    Engelhart James, Chief Financial Officer

    Sold 75.8% of holdings ($4.7M position)11,196 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Engelhart James
Source
Dec 10, 2021Dec 10, 2021Biohaven Pharmaceutical Holding Co Ltd.Chief Financial OfficerForm 4 sale35,000$3.6M75.8%UnusualSEC
Jun 11, 2020Jun 12, 2020Biohaven Pharmaceutical Holding Co Ltd.Chief Financial OfficerForm 4 sale73,725$4.9M94.2%UnusualSEC
May 30, 2018May 30, 2018Biohaven Pharmaceutical Holding Co Ltd.Chief Financial OfficerForm 4 sale5,000$175k100.0%UnusualSEC
May 7, 2018May 9, 2018Biohaven Pharmaceutical Holding Co Ltd.Chief Financial OfficerForm 4 sale2,500$69k100.0%UnusualSEC
Feb 21, 2018Feb 23, 2018Biohaven Pharmaceutical Holding Co Ltd.Chief Financial OfficerForm 4 sale538$16k15.0%Plan not statedSEC
Jan 22, 2018Jan 24, 2018Biohaven Pharmaceutical Holding Co Ltd.Chief Financial OfficerForm 4 sale10,000$325k73.7%UnusualSEC
Nov 10, 2017Nov 14, 2017Biohaven Pharmaceutical Holding Co Ltd.Chief Financial OfficerForm 4 sale30,538$812k89.5%UnusualSEC